Sedana Medical AB (publ)
STO:SEDANA
Sedana Medical AB (publ)
Operating Income
Sedana Medical AB (publ)
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Operating Income
-kr50.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Operating Income
kr2.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Operating Income
kr144.3m
|
CAGR 3-Years
37%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Operating Income
kr177.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
Getinge AB
STO:GETI B
|
Operating Income
kr3.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Operating Income
kr1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Sedana Medical AB (publ)
Glance View
Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
See Also
What is Sedana Medical AB (publ)'s Operating Income?
Operating Income
-50.8m
SEK
Based on the financial report for Dec 31, 2024, Sedana Medical AB (publ)'s Operating Income amounts to -50.8m SEK.
What is Sedana Medical AB (publ)'s Operating Income growth rate?
Operating Income CAGR 5Y
-22%
Over the last year, the Operating Income growth was 24%. The average annual Operating Income growth rates for Sedana Medical AB (publ) have been 6% over the past three years , -22% over the past five years .
You don't have any saved screeners yet